Tau imaging is suggested to be more closely related to cognitive decline and neurodegeneration than amyloid-β imaging and, therefore, tau PET is a useful approach for accurate AD staging and its prognosis (Schwarz et al. 2018; Bucci et al. 2021). This evidence concerns the gene MAPT and Alzheimer disease.